Market Tracker

02/27 6:02pm ET

Immunomedics Inc (NASDAQ:IMMU)

4.08
Delayed Data
As of Feb 27
 -0.01 / -0.24%
Today’s Change
3.04
Today|||52-Week Range
5.48
-15.00%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close4.09
Today’s open4.09
Day’s range4.06 - 4.11
Volume587,570
Average volume (3 months)1,005,992
Market cap$380.1M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales44.93
Price/Book9.63

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc-0.65-2.90%
LMNSLumenis Ltd+0.43+3.85%
CLDNCelladon Corp+0.37+2.08%
ARDXArdelyx Inc-0.27-1.66%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts